Xiaofeng Jin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Plant Gene Expression Analysis
- RNA modifications and cancer
- Photosynthetic Processes and Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 36
- Histone Deacetylase Inhibitors Research 11
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 8
- Oncology 25
- Cancer-related Molecular Pathways 14
- Peptidase Inhibition and Analysis 7
- Co-authors
- Ri‐He Peng (5 shared papers)Feng Gao (4 shared papers)Jing Zhuang (4 shared papers)Xiaoyan Fu (4 shared papers)Ai‐Sheng Xiong (4 shared papers)Yushan Qiao (3 shared papers)Bin Cai (2 shared papers)Haojie Huang (6 shared papers)
- Journals
- Gene (10 papers)Journal of Molecular Medicine (5 papers)Molecular Biology Reports (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiaofeng Jin
86 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 274
- Molecular Biology 1.1k
- Plant Science 424
- Cell Biology 116
- Oncology 168
Countries citing papers authored by Xiaofeng Jin
This map shows the geographic impact of Xiaofeng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Jin more than expected).
Fields of papers citing papers by Xiaofeng Jin
This network shows the impact of papers produced by Xiaofeng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Jin. The network helps show where Xiaofeng Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 256 | |
| 2 | 2009 | 99 | |
| 3 | 2009 | 68 | |
| 4 | 2017 | 59 | |
| 5 | 2019 | 52 | |
| 6 | 2015 | 50 | |
| 7 | 2012 | 40 | |
| 8 | 2022 | 37 | |
| 9 | 2015 | 35 | |
| 10 | Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells. | 2015 | 35 |
| 11 | 2009 | 33 | |
| 12 | 2022 | 32 | |
| 13 | 2014 | 30 | |
| 14 | 2018 | 28 | |
| 15 | 2017 | 26 | |
| 16 | 2021 | 26 | |
| 17 | 2018 | 24 | |
| 18 | The roles of E3 ligases in Hepatocellular carcinoma. | 2022 | 21 |
| 19 | 2016 | 20 | |
| 20 | 2021 | 20 |
About Xiaofeng Jin
Xiaofeng Jin is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Cell Biology, having authored 90 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (36 papers), Cancer-related Molecular Pathways (14 papers), Histone Deacetylase Inhibitors Research (11 papers), RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Epigenetics and DNA Methylation (8 papers), Prostate Cancer Treatment and Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (1.1k citations), Plant Science (424 citations), Cell Biology (116 citations) and Oncology (168 citations). Xiaofeng Jin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ri‐He Peng, Feng Gao, Jing Zhuang, Xiaoyan Fu, Ai‐Sheng Xiong, Yushan Qiao, Bin Cai, Haojie Huang, Wei Zhao and Yong‐Sheng Tian. Their work appears in journals such as Gene, Journal of Molecular Medicine, Molecular Biology Reports, Journal of Cancer Research and Clinical Oncology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.